Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Statewide analysis of missed opportunities for human papillomavirus vaccination using vaccine registry data.

Kepka D, Spigarelli MG, Warner EL, Yoneoka Y, McConnell N, Balch A.

Papillomavirus Res. 2016 Dec;2:128-132.

2.

Use of Oxandrolone to Promote Growth in Neonates following Surgery for Complex Congenital Heart Disease: An Open-Label Pilot Trial.

Burch PT, Spigarelli MG, Lambert LM, Loftus PD, Sherwin CM, Linakis MW, Sheng X, LuAnn Minich L, Williams RV.

Congenit Heart Dis. 2016 Dec;11(6):693-699. doi: 10.1111/chd.12376. Epub 2016 Jun 3.

PMID:
27257953
3.

Therapeutic Drug Monitoring of Ganciclovir Treatment for Cytomegalovirus Infections Among Immunocompromised Children.

Stockmann C, Sherwin CM, Knackstedt ED, Hersh AL, Pavia AT, Spigarelli MG.

J Pediatric Infect Dis Soc. 2016 Mar 8. pii: piw008. [Epub ahead of print] No abstract available.

PMID:
26962197
4.

High school females and those with other vaccinations most likely to complete the Human Papillomavirus vaccine.

Kepka D, Ding Q, Warner EL, Spigarelli MG, Mooney K.

Prev Med Rep. 2015 Jan 6;2:79-83. doi: 10.1016/j.pmedr.2014.12.008. eCollection 2015.

5.

Evaluation of Vancomycin Use in Late-Onset Neonatal Sepsis Using the Area Under the Concentration-Time Curve to the Minimum Inhibitory Concentration ≥400 Target.

Bhongsatiern J, Stockmann C, Roberts JK, Yu T, Korgenski KE, Spigarelli MG, Desai PB, Sherwin CM.

Ther Drug Monit. 2015 Dec;37(6):756-65. doi: 10.1097/FTD.0000000000000216.

6.

Renal Function Descriptors in Neonates: Which Creatinine-Based Formula Best Describes Vancomycin Clearance?

Bhongsatiern J, Stockmann C, Yu T, Constance JE, Moorthy G, Spigarelli MG, Desai PB, Sherwin CM.

J Clin Pharmacol. 2016 May;56(5):528-40. doi: 10.1002/jcph.650. Epub 2015 Dec 18. Review.

PMID:
26412385
7.

Special population considerations and regulatory affairs for clinical research.

Grimsrud KN, Sherwin CM, Constance JE, Tak C, Zuppa AF, Spigarelli MG, Mihalopoulos NL.

Clin Res Regul Aff. 2015;32(2):47-56.

8.

A propensity-matched cohort study of vancomycin-associated nephrotoxicity in neonates.

Constance JE, Balch AH, Stockmann C, Linakis MW, Korgenski EK, Roberts JK, Ward RM, Sherwin CM, Spigarelli MG.

Arch Dis Child Fetal Neonatal Ed. 2016 May;101(3):F236-43. doi: 10.1136/archdischild-2015-308459. Epub 2015 Sep 23.

PMID:
26400103
9.

Pregnancy-induced changes in the pharmacokinetics of caffeine and its metabolites.

Yu T, Campbell SC, Stockmann C, Tak C, Schoen K, Clark EA, Varner MW, Spigarelli MG, Sherwin CM.

J Clin Pharmacol. 2016 May;56(5):590-6. doi: 10.1002/jcph.632. Epub 2015 Dec 22.

10.

Comanagement of Pediatric Depression and Obesity: A Clear Need for Evidence.

Mihalopoulos NL, Spigarelli MG.

Clin Ther. 2015 Sep 1;37(9):1933-7. doi: 10.1016/j.clinthera.2015.08.009. Epub 2015 Aug 29. Review.

11.

Challenges Associated with Route of Administration in Neonatal Drug Delivery.

Linakis MW, Roberts JK, Lala AC, Spigarelli MG, Medlicott NJ, Reith DM, Ward RM, Sherwin CM.

Clin Pharmacokinet. 2016 Feb;55(2):185-96. doi: 10.1007/s40262-015-0313-z. Review.

PMID:
26245673
12.

Quantitative Assay Validation for Oxandrolone in Human Plasma Using LC-MS-MS.

Linakis MW, Stockmann C, Campbell SC, Williams RV, Burch PT, Lambert LM, Sherwin CM, Reilly CA, Spigarelli MG.

J Anal Toxicol. 2015 Sep;39(7):526-31. doi: 10.1093/jat/bkv056. Epub 2015 May 27.

PMID:
26017381
13.

Predictive Performance of a Vancomycin Population Pharmacokinetic Model in Neonates.

Stockmann C, Hersh AL, Roberts JK, Bhongsatiern J, Korgenski EK, Spigarelli MG, Sherwin CM, Frymoyer A.

Infect Dis Ther. 2015 Jun;4(2):187-98. doi: 10.1007/s40121-015-0067-9. Epub 2015 May 22.

14.

Darbepoetin administration to neonates undergoing cooling for encephalopathy: a safety and pharmacokinetic trial.

Baserga MC, Beachy JC, Roberts JK, Ward RM, DiGeronimo RJ, Walsh WF, Ohls RK, Anderson J, Mayock DE, Juul SE, Christensen RD, Loertscher MC, Stockmann C, Sherwin CM, Spigarelli MG, Yoder BA.

Pediatr Res. 2015 Sep;78(3):315-22. doi: 10.1038/pr.2015.101. Epub 2015 May 21.

15.

Population Pharmacokinetics of Darbepoetin Alfa in Conjunction with Hypothermia for the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy.

Roberts JK, Stockmann C, Ward RM, Beachy J, Baserga MC, Spigarelli MG, Sherwin CM.

Clin Pharmacokinet. 2015 Dec;54(12):1237-44. doi: 10.1007/s40262-015-0286-y.

16.

Effect of CYP3A5*3 on asthma control among children treated with inhaled beclomethasone.

Stockmann C, Reilly CA, Fassl B, Gaedigk R, Nkoy F, Stone B, Roberts JK, Uchida DA, Leeder JS, Sherwin CM, Spigarelli MG, Yost GS, Ward RM.

J Allergy Clin Immunol. 2015 Aug;136(2):505-7. doi: 10.1016/j.jaci.2015.02.009. Epub 2015 Mar 29. No abstract available.

17.

National trends in the incidence, outcomes and charges of pediatric osteoarticular infections, 1997-2012.

Stockmann C, Ampofo K, Pavia AT, Byington CL, Blaschke AJ, Sherwin CM, Spigarelli MG, Hersh AL.

Pediatr Infect Dis J. 2015 Jun;34(6):672-4. doi: 10.1097/INF.0000000000000686.

PMID:
25806839
18.

Application of a method used to deconstruct a single dose pharmacokinetic profile from multiple dose data.

Stockmann C, Spigarelli MG, Healy DP, Gottschlich MM, Kagan R, Balch AH, Sherwin C.

Biopharm Drug Dispos. 2015 Mar 12. doi: 10.1002/bdd.1949. [Epub ahead of print]

PMID:
25766031
19.

Optimal design in pediatric pharmacokinetic and pharmacodynamic clinical studies.

Roberts JK, Stockmann C, Balch A, Yu T, Ward RM, Spigarelli MG, Sherwin CM.

Paediatr Anaesth. 2015 Mar;25(3):222-30. doi: 10.1111/pan.12575. Epub 2015 Jan 9. Review.

PMID:
25580772
20.
21.

An extensive pharmacokinetic, metabolic and toxicological review of elderly patients under intensive chemotherapy for acute myeloid leukemia.

Kaur I, Constance JE, Kosak KM, Spigarelli MG, Sherwin CM.

Expert Opin Drug Metab Toxicol. 2015 Jan;11(1):53-65. doi: 10.1517/17425255.2015.972934. Epub 2014 Dec 9. Review.

PMID:
25488904
22.

Rate of asthma trial outcomes reporting on ClinicalTrials.gov and in the published literature.

Stockmann C, Ross JS, Sherwin CMT, Reilly CA, McDowell B, Fassl B, Nkoy F, Maloney CG, Spigarelli MG.

J Allergy Clin Immunol. 2014 Dec;134(6):1443-1446. doi: 10.1016/j.jaci.2014.09.019. Epub 2014 Oct 28. No abstract available.

23.

Clinical pharmacokinetics and pharmacodynamics of ganciclovir and valganciclovir in children with cytomegalovirus infection.

Stockmann C, Roberts JK, Knackstedt ED, Spigarelli MG, Sherwin CM.

Expert Opin Drug Metab Toxicol. 2015 Feb;11(2):205-19. doi: 10.1517/17425255.2015.988139. Epub 2014 Nov 27. Review.

PMID:
25428442
24.

Levofloxacin inhalation solution for the treatment of chronic Pseudomonas aeruginosa infection among patients with cystic fibrosis.

Stockmann C, Hillyard B, Ampofo K, Spigarelli MG, Sherwin CM.

Expert Rev Respir Med. 2015 Feb;9(1):13-22. doi: 10.1586/17476348.2015.986469. Epub 2014 Nov 24. Review.

PMID:
25417708
25.

Neonatal magnesium levels correlate with motor outcomes in premature infants: a long-term retrospective cohort study.

Doll E, Wilkes J, Cook LJ, Korgenski EK, Faix RG, Yoder BA, Srivastava R, Sherwin CM, Spigarelli MG, Clark EA, Bonkowsky JL.

Front Pediatr. 2014 Nov 5;2:120. doi: 10.3389/fped.2014.00120. eCollection 2014.

26.
27.

Epidemiological Evaluation of Blood Culture Patterns among Neonates Receiving Vancomycin.

Yakub SY, Constance JE, Stockmann C, Linakis M, Campbell SC, Sherwin CM, Korgenski EK, Balch A, Spigarelli MG.

Indian J Microbiol. 2014 Dec;54(4):389-95. doi: 10.1007/s12088-014-0478-4. Epub 2014 Jun 17.

28.

Vancomycin pharmacokinetic models: informing the clinical management of drug-resistant bacterial infections.

Stockmann C, Roberts JK, Yu T, Constance JE, Knibbe CA, Spigarelli MG, Sherwin CM.

Expert Rev Anti Infect Ther. 2014 Nov;12(11):1371-88. doi: 10.1586/14787210.2014.966081. Review.

PMID:
25301231
29.

Pediatric vancomycin dosing: Trends over time and the impact of therapeutic drug monitoring.

Balch AH, Constance JE, Thorell EA, Stockmann C, Korgenski EK, Campbell SC, Spigarelli MG, Sherwin CM.

J Clin Pharmacol. 2015 Feb;55(2):212-20. doi: 10.1002/jcph.402. Epub 2014 Nov 7.

30.

Development of an optimal sampling schedule for children receiving ketamine for short-term procedural sedation and analgesia.

Sherwin CM, Stockmann C, Grimsrud K, Herd DW, Anderson BJ, Spigarelli MG.

Paediatr Anaesth. 2015 Feb;25(2):211-6. doi: 10.1111/pan.12521. Epub 2014 Sep 12.

PMID:
25212712
31.

Relationship between zolpidem concentrations and sleep parameters in pediatric burn patients.

Stockmann C, Gottschlich MM, Healy D, Khoury JC, Mayes T, Sherwin CM, Spigarelli MG, Kagan RJ.

J Burn Care Res. 2015 Jan-Feb;36(1):137-44. doi: 10.1097/BCR.0000000000000164.

32.

Determination of Optimal Amikacin Dosing Regimens for Pediatric Patients With Burn Wound Sepsis.

Yu T, Stockmann C, Healy DP, Olson J, Wead S, Neely AN, Kagan RJ, Spigarelli MG, Sherwin CM.

J Burn Care Res. 2015 Jul-Aug;36(4):e244-52. doi: 10.1097/BCR.0000000000000159.

PMID:
25185930
33.

Age-Specific Patterns of Influenza Activity in Utah: Do Older School Age Children Drive the Epidemic?

Stockmann C, Pavia AT, Hersh AL, Spigarelli MG, Castle B, Korgenski K, Byington CL, Ampofo K.

J Pediatric Infect Dis Soc. 2014 Jun;3(2):163-7. doi: 10.1093/jpids/pit004. Epub 2013 Feb 14.

34.

Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.

Roberts JK, Stockmann C, Constance JE, Stiers J, Spigarelli MG, Ward RM, Sherwin CM.

Clin Pharmacokinet. 2014 Jul;53(7):581-610. doi: 10.1007/s40262-014-0147-0. Review.

PMID:
24871768
35.

Low human papillomavirus (HPV) vaccine knowledge among Latino parents in Utah.

Kepka D, Warner EL, Kinney AY, Spigarelli MG, Mooney K.

J Immigr Minor Health. 2015 Feb;17(1):125-31. doi: 10.1007/s10903-014-0003-1.

PMID:
24609357
36.

Pharmacokinetics and pharmacodynamics of antifungals in children and their clinical implications.

Stockmann C, Constance JE, Roberts JK, Olson J, Doby EH, Ampofo K, Stiers J, Spigarelli MG, Sherwin CM.

Clin Pharmacokinet. 2014 May;53(5):429-54. doi: 10.1007/s40262-014-0139-0. Review.

37.

Intrapartum magnesium sulfate and the potential for cardiopulmonary drug-drug interactions.

Campbell SC, Stockmann C, Balch A, Clark EA, Kamyar M, Varner M, Korgenski EK, Bonkowsky JL, Spigarelli MG, Sherwin CM.

Ther Drug Monit. 2014 Aug;36(4):544-8. doi: 10.1097/FTD.0000000000000050.

38.

Alignment of United States funding for cardiovascular disease research with deaths, years of life lost, and hospitalizations.

Stockmann C, Hersh AL, Sherwin CM, Spigarelli MG.

Int J Cardiol. 2014 Mar 1;172(1):e19-21. doi: 10.1016/j.ijcard.2013.12.095. Epub 2014 Jan 5. No abstract available.

PMID:
24439868
39.

Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity.

Schoen K, Yu T, Stockmann C, Spigarelli MG, Sherwin CM.

Paediatr Drugs. 2014 Apr;16(2):169-77. doi: 10.1007/s40272-013-0063-z. Review.

40.

Pharmacokinetic and pharmacodynamic optimisation of intravenous tobramycin dosing among children with cystic fibrosis.

Sherwin CM, Zobell JT, Stockmann C, McCrory BE, Wisdom M, Young DC, Olson J, Ampofo K, Spigarelli MG.

J Pharmacokinet Pharmacodyn. 2014 Feb;41(1):71-9. doi: 10.1007/s10928-013-9348-7. Epub 2014 Jan 7.

PMID:
24395072
41.

Preliminary assessment of zolpidem pharmacokinetics in pediatric burn patients.

Stockmann C, Sherwin CM, Buterbaugh W, Spigarelli MG, Gottschlich MM, Healy D, Kagan RJ.

Ther Drug Monit. 2014 Jun;36(3):295-301. doi: 10.1097/FTD.0000000000000017.

PMID:
24365985
42.

Development of levofloxacin inhalation solution to treat Pseudomonas aeruginosa in patients with cystic fibrosis.

Stockmann C, Sherwin CM, Ampofo K, Spigarelli MG.

Ther Adv Respir Dis. 2014 Feb;8(1):13-21. doi: 10.1177/1753465813508445. Epub 2013 Dec 10. Review.

43.

Considerations in the pharmacologic treatment and prevention of neonatal sepsis.

Stockmann C, Spigarelli MG, Campbell SC, Constance JE, Courter JD, Thorell EA, Olson J, Sherwin CM.

Paediatr Drugs. 2014 Feb;16(1):67-81. doi: 10.1007/s40272-013-0057-x. Review.

PMID:
24218112
44.

Evolution of interventional vancomycin trials in light of new antibiotic development in the USA, 1999-2012.

Yu T, Stockmann C, Balch AH, Spigarelli MG, Sherwin CM.

Int J Antimicrob Agents. 2014 Mar;43(3):215-22. doi: 10.1016/j.ijantimicag.2013.10.002. Epub 2013 Oct 16. Review.

PMID:
24183801
45.

Characteristics and publication patterns of obstetric studies registered in ClinicalTrials.gov.

Stockmann C, Sherwin CM, Koren G, Campbell SC, Constance JE, Linakis M, Balch A, Varner MW, Spigarelli MG.

J Clin Pharmacol. 2014 Apr;54(4):432-7. doi: 10.1002/jcph.212. Epub 2013 Nov 14.

46.

Maternal magnesium sulphate exposure predicts neonatal magnesium blood concentrations.

Sherwin CM, Balch A, Campbell SC, Fredrickson J, Clark EA, Varner M, Stockmann C, Korgenski EK, Bonkowsky JL, Spigarelli MG.

Basic Clin Pharmacol Toxicol. 2014 Apr;114(4):318-22. doi: 10.1111/bcpt.12166. Epub 2013 Dec 11.

47.

Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: V. Aminoglycosides.

Young DC, Zobell JT, Stockmann C, Waters CD, Ampofo K, Sherwin CM, Spigarelli MG.

Pediatr Pulmonol. 2013 Nov;48(11):1047-61. doi: 10.1002/ppul.22813. Epub 2013 Sep 2. Review.

PMID:
24000183
48.

Amikacin population pharmacokinetics among paediatric burn patients.

Sherwin CM, Wead S, Stockmann C, Healy D, Spigarelli MG, Neely A, Kagan R.

Burns. 2014 Mar;40(2):311-8. doi: 10.1016/j.burns.2013.06.015. Epub 2013 Jul 19.

PMID:
23876785
49.

Population pharmacokinetics of intermittent vancomycin in children with cystic fibrosis.

Stockmann C, Sherwin CM, Zobell JT, Lubsch L, Young DC, Olson J, Noyes BE, Ampofo K, Spigarelli MG.

Pharmacotherapy. 2013 Dec;33(12):1288-96. doi: 10.1002/phar.1320. Epub 2013 Jul 3.

PMID:
23824677
50.

Characteristics of antimicrobial studies registered in the USA through ClinicalTrials.Gov.

Stockmann C, Sherwin CM, Ampofo K, Hersh AL, Pavia AT, Byington CL, Ward RM, Spigarelli MG.

Int J Antimicrob Agents. 2013 Aug;42(2):161-6. doi: 10.1016/j.ijantimicag.2013.04.019. Epub 2013 May 30.

Supplemental Content

Loading ...
Support Center